Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Conatus Pharmaceuticals Inc. (CNAT)

« Back to company index

CNAT Chatter Timeline

Stock Ticker for CNAT

Most Active Tweeters for CNAT

No tweets found

Recent Tweets for CNAT

registrarjourn @registrarjourn
Conatus Pharmaceuticals $CNAT Given a $14.00 Price Target at Oppenheimer https://t.co/klM284CtYp
August 21st 2018, 8:08pm
EnterpriseLeade @EnterpriseLeade
Conatus Pharmaceuticals $CNAT Given a $14.00 Price Target at Oppenheimer https://t.co/LasXyYRvfg
August 21st 2018, 8:08pm
usindexlive @usindexlive
Mpm Asset Management Increased Holding in Conatus Pharmaceuticals $CNAT by $1.82 Million; Advisor Partners Raised… https://t.co/aVRM1PngKV
August 21st 2018, 12:08pm
dailypoliticaln @dailypoliticaln
Zacks: Brokerages Expect Conatus Pharmaceuticals Inc $CNAT to Post -$0.13 EPS https://t.co/ixAqXyScG0
August 21st 2018, 12:08am
TickerReport @TickerReport
-$0.13 EPS Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/OO5ft9ADvt
August 21st 2018, 12:08am
MareaInformativ @MareaInformativ
-$0.13 EPS Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/Npw5A9GGiW
August 21st 2018, 12:08am
AmericanBanking @AmericanBanking
-$0.13 EPS Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/jkdmgjnW0Y #stocks
August 21st 2018, 12:08am
usindexlive @usindexlive
Grandfield & Dodd Has Lowered Its Chevron New $CVX Position; Conatus Pharmaceuticals Inc. $CNAT Had 3 Bulls https://t.co/IQDoiWOdQB
August 19th 2018, 8:08am
registrarjourn @registrarjourn
$9.06 Million in Sales Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/w6W4N9dRjU
August 18th 2018, 12:08pm
registrarjourn @registrarjourn
Conatus Pharmaceuticals Inc $CNAT Receives $12.14 Consensus Price Target from Brokerages https://t.co/a5HdiHWcvP
August 17th 2018, 12:08pm
bibeypost_stock @bibeypost_stock
Conatus Pharmaceuticals Inc's $CNAT Sentiment is 1.11 - https://t.co/nDXOZwzleX
August 16th 2018, 11:08am
whatsonthorold2 @whatsonthorold2
Conatus Pharmaceuticals Inc $CNAT Sentiment Up in Q1 2018 - https://t.co/B6w7Xv9vlJ
August 16th 2018, 11:08am
Fanob_stock @Fanob_stock
Conatus Pharmaceuticals Inc $CNAT: Positive Stock Sentiment https://t.co/4Z70yqtOIL
August 16th 2018, 11:08am
ChartMill @ChartMill
$CNAT shows a strong growth in EPS: 53.44%. https://t.co/0o8bQehZX2 https://t.co/PLoGM7bBEf
August 15th 2018, 11:08am
4thQuarterCap @4thQuarterCap
Sold $CNAT traders +5%
August 14th 2018, 12:08am
MareaInformativ @MareaInformativ
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Earnings of -$0.20 Per Share https://t.co/htBK9MjbXW
August 13th 2018, 9:08pm
MareaInformativ @MareaInformativ
Analysts Expect Conatus Pharmaceuticals Inc $CNAT Will Announce Quarterly Sales of $9.06 Million https://t.co/AH57nhhgry
August 13th 2018, 9:08pm
MareaInformativ @MareaInformativ
$10.84 Million in Sales Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/lWB2Z9VQTt
August 13th 2018, 11:08am
TranscriptDaily @TranscriptDaily
Zacks: Analysts Expect Conatus Pharmaceuticals Inc $CNAT Will Post Quarterly Sales of $10.25 Million https://t.co/dMlYv66hAU
August 10th 2018, 5:08pm
ChartMill @ChartMill
$CNAT has a bad technical rating, but it does show a decent setup pattern. https://t.co/3JhzULrUeo https://t.co/sBcIPVBwhD
August 10th 2018, 3:08pm
beyond_ninety @beyond_ninety
Mpm Asset Management Stake in Conatus Pharmaceuticals $CNAT Upped by $1.82 Million as Market Value Declined; Roffm… https://t.co/0nHxoinwuz
August 10th 2018, 5:08am
Rob_Is_SIC @Rob_Is_SIC
$CNAT ?
August 9th 2018, 12:08pm
dakotafinancial @dakotafinancial
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Quarterly Sales of $10.25 Million https://t.co/F4xvRFrVcP
August 8th 2018, 4:08pm
MareaInformativ @MareaInformativ
Brokerages Expect Conatus Pharmaceuticals Inc $CNAT to Post -$0.13 Earnings Per Share https://t.co/XN2A4XkNoN
August 8th 2018, 4:08pm
dakotafinancial @dakotafinancial
Brokerages Expect Conatus Pharmaceuticals Inc $CNAT to Post -$0.13 Earnings Per Share https://t.co/qt61i8tf2R
August 8th 2018, 3:08pm
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Conatus Pharmaceuticals Inc $CNAT to Post -$0.13 Earnings Per Share https://t.co/S6V6IQwkTx
August 8th 2018, 3:08pm
ZolmaxNews @ZolmaxNews
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Quarterly Sales of $10.25 Million https://t.co/KsqvRtpD5S
August 8th 2018, 3:08pm
ChartMill @ChartMill
$CNAT: The EPS is expected to grow by 40.59% on average over the next 2 years. This is a very strong growth.… https://t.co/NVS0rjl1Gq
August 8th 2018, 5:08am
MareaInformativ @MareaInformativ
Short Interest in Conatus Pharmaceuticals Inc $CNAT Drops By 32.0% https://t.co/eOin603nJB
August 7th 2018, 6:08pm
MareaInformativ @MareaInformativ
Conatus Pharmaceuticals $CNAT Earning Somewhat Positive News Coverage, Accern Reports https://t.co/oIbENiAS2V
August 7th 2018, 12:08pm
bbnsnews @bbnsnews
-$0.15 Earnings Per Share Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/5kBDQnLgx0
August 7th 2018, 12:08pm
dispatchtribune @dispatchtribune
Conatus Pharmaceuticals $CNAT Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/OOHSIIt563
August 7th 2018, 2:08am
TheMarketsDaily @TheMarketsDaily
Conatus Pharmaceuticals Inc $CNAT Expected to Post Quarterly Sales of $10.84 Million https://t.co/gAJEHRaYH1
August 7th 2018, 1:08am
AmericanBanking @AmericanBanking
$10.84 Million in Sales Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/aEB3tnXplp #stocks
August 7th 2018, 1:08am
TickerReport @TickerReport
Oppenheimer Reiterates $14.00 Price Target for Conatus Pharmaceuticals $CNAT https://t.co/RIT6SwF6Xz
August 5th 2018, 4:08pm
ConsumerFeed @ConsumerFeed
Oppenheimer Reiterates $14.00 Price Target for Conatus Pharmaceuticals $CNAT https://t.co/2MYlZujsnG
August 5th 2018, 4:08pm
ThisLincolnian @ThisLincolnian
Conatus Pharmaceuticals $CNAT PT Set at $14.00 by Oppenheimer https://t.co/tCWV6MDgG4
August 4th 2018, 3:08am
dispatchtribune @dispatchtribune
Conatus Pharmaceuticals $CNAT Given a $14.00 Price Target at Oppenheimer https://t.co/WgXK5bSnW6
August 3rd 2018, 11:08pm
OlympiaReport @OlympiaReport
Conatus Pharmaceuticals $CNAT Given a $14.00 Price Target at Oppenheimer https://t.co/mohxIVnqEu
August 3rd 2018, 11:08pm
WeekHerald @WeekHerald
Conatus Pharmaceuticals $CNAT Announces Quarterly Earnings Results https://t.co/06at1NGhco
August 3rd 2018, 9:08pm
ThisLincolnian @ThisLincolnian
Conatus Pharmaceuticals $CNAT Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/GYa7an1zC4
August 3rd 2018, 9:08pm
dakotafinancial @dakotafinancial
Conatus Pharmaceuticals $CNAT Announces Earnings Results, Beats Expectations By $0.05 EPS https://t.co/EPADaT9ZdE
August 3rd 2018, 8:08pm
dailypoliticaln @dailypoliticaln
Conatus Pharmaceuticals $CNAT Announces Quarterly Earnings Results https://t.co/xVwobtblw9
August 3rd 2018, 8:08pm
ThisLincolnian @ThisLincolnian
-$0.15 EPS Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/FwBVM9Q1uP
August 3rd 2018, 6:08pm
ichi_hsu @ichi_hsu
RT @alanhobbes: @alanhobbes comments on #Conatus $CNAT Q2-2018 update and its Phase 2b ENCORE program at https://t.co/O6aADJvrwY
August 3rd 2018, 6:08pm
alanhobbes @alanhobbes
@alanhobbes comments on #Conatus $CNAT Q2-2018 update and its Phase 2b ENCORE program at https://t.co/O6aADJvrwY
August 3rd 2018, 6:08pm
OpenOutcrier @OpenOutcrier
$CNAT (-2.5% pre) $35m ATM offering through Stifel - Form 424B5 https://t.co/QQAoOeF94t
August 3rd 2018, 8:08am
AmericanBanking @AmericanBanking
Conatus Pharmaceuticals $CNAT Announces Quarterly Earnings Results https://t.co/JwXtN4LQuY #stocks
August 3rd 2018, 1:08am
ZolmaxNews @ZolmaxNews
Conatus Pharmaceuticals $CNAT Announces Quarterly Earnings Results https://t.co/z5PCY7HhTK
August 3rd 2018, 12:08am
kuritzmike @kuritzmike
RT @shaneblackmon: $CNAT $35m ATM offering through Stifel
August 2nd 2018, 11:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.